The Gleason score is a well-established indicator of prognostic significance in patients with prostate cancer, but there is still debate about how best to treat men with a Gleason score of 7 (3+4 ...

The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...

Gleason 7: The cancer is intermediate-grade or ... is an important figure for understanding a prostate cancer prognosis, it doesn’t tell the whole story. Pathologists also consider the ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies.However, in addition to being uncomfortable, some of these ...

Do you consider the cancer measurements to be small, thus making the “observation only” protocol correct? — B.A. Dear B.A.: ...

Biopsy confirmed Gleason grade 7 prostate cancer. Elastography images are courtesy of Dennis Cochlin, University Hospital of Wales, UK and published with permission from Toshiba Medical Systems ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including milk thistle, turmeric, and green tea, that target the tumor ...

In a population of patients with initial PSA levels less then 3.0 ng/ml, 21% had prostate cancer on biopsy; 46 of these men, 20.6% had Gleason score 7 or higher disease and 4.7% had Gleason score ...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

A new review led by researchers at Moffitt Cancer Center assessed how three genomic tests - Decipher, Oncotype DX Genomic Prostate Score (GPS) and Prolaris - can help doctors make better decisions ...